Rheonix Secures $14,000,000 New Round

  • Feed Type
  • Date
    12/19/2013
  • Company Name
    Rheonix
  • Mailing Address
    22 Thornwood Drive Ithaca, NY 14850
  • Company Description
    Rheonix, Inc. is exploiting its novel, patented, polymer chip microfluidic technology to introduce products that address some of the hottest issues in global healthcare today: Avian Influenza, HPV, TB, Dengue Fever, AIDS, SARS, bioterrorism, affordable healthcare in developing nations, personalized medicine, and molecular diagnostics, to name a few.
  • Website
    http://www.rheonix.com
  • Transaction Type
    Debt, Venture Equity
  • Transaction Amount
    $14,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The funds will be used to expand the company’s physical operations to produce consumables and systems to fulfill Rheonix’s joint development agreement with Life Technologies Corp. and for the commercialization of its first clinical, molecular diagnostic product offering.
  • M&A Terms
  • Venture Investor
    Cayuga Venture Fund
  • Venture Investor
    Rand Capital
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.